{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:38Z","timestamp":1761155318944},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.critrevonc.2009.11.007","type":"journal-article","created":{"date-parts":[[2009,12,31]],"date-time":"2009-12-31T09:07:52Z","timestamp":1262250472000},"page":"235-242","source":"Crossref","is-referenced-by-count":8,"title":["Preoperative radiochemotherapy for resectable localised oesophageal cancer: A controversial strategy"],"prefix":"10.1016","volume":"75","author":[{"given":"G.","family":"Crehange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Peignaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Truc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chauffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ghiringhelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2009.11.007_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jama.1991.03460100089030","article-title":"Rising incidence of adenocarcinoma of the esophagus and gastric cardia","volume":"265","author":"Blot","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib2","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0959-8049(03)00360-5","article-title":"Comparison of stomach cancer incidence and survival in four continents","volume":"39","author":"Verdecchia","year":"2003","journal-title":"Eur J Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.critrevonc.2009.11.007_bib3","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990\u201394\u2014results and commentary","volume":"14","author":"Sant","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ejca.2008.04.010","article-title":"Should the EU also wage war against cancer? And if so, how? Foreword and afterthoughts to this special issue on cancer control at the European level","volume":"44","author":"Coebergh","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","article-title":"Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world","volume":"234","author":"Siewert","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00268-004-7542-x","article-title":"Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma","volume":"29","author":"Mariette","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncr.21601","article-title":"Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy","volume":"106","author":"Rohatgi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/oxfordjournals.jjco.a023238","article-title":"Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial","volume":"26","author":"Ishida","year":"1996","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib9","series-title":"Surgery for cancer of the esophagus","author":"Akiyama","year":"1990"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00000658-198702000-00014","article-title":"Local recurrences after subtotal esophagectomy for squamous cell carcinoma","volume":"205","author":"Tam","year":"1987","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bjs.1800670602","article-title":"Oesophageal squamous cell carcinoma. I. A critical review of surgery","volume":"67","author":"Earlam","year":"1980","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib13","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa022343","article-title":"Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus","volume":"347","author":"Hulscher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00000658-198110000-00007","article-title":"Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement","volume":"194","author":"Akiyama","year":"1981","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/01.sla.0000145925.70409.d7","article-title":"Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma","volume":"240","author":"Lerut","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9610(97)00227-4","article-title":"A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus","volume":"175","author":"Nishihira","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00104-005-1096-9","article-title":"Esophagectomy as therapeutic principle for squamous cell esophageal cancer","volume":"76","author":"Siewert","year":"2005","journal-title":"Chirurg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0003-4975(00)02570-4","article-title":"Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis","volume":"72","author":"Hulscher","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib19","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S1470-2045(06)70766-5","article-title":"Left thoracoabdominal approach versus abdominal\u2013transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial","volume":"7","author":"Sasako","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2168.1999.01082.x","article-title":"Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group","volume":"86","author":"Wijnhoven","year":"1999","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.20358","article-title":"Differences and similarities of adenocarcinomas of the esophagus and esophagogastric junction","volume":"92","author":"Marsman","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jamcollsurg.2004.08.015","article-title":"Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?","volume":"199","author":"Ito","year":"2004","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000255563.65157.d2","article-title":"Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome","volume":"246","author":"Barbour","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM199903253401202","article-title":"Extended lymph-node dissection for gastric cancer","volume":"340","author":"Bonenkamp","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6690243","article-title":"Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group","volume":"79","author":"Cuschieri","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib26","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.2004.08.026","article-title":"Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial","volume":"22","author":"Hartgrink","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00000658-199810000-00002","article-title":"Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study","volume":"228","author":"Siewert","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib28","first-page":"391","article-title":"A prospective study of combined therapy in esophageal cancer","volume":"41","author":"Apinop","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib30","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T","article-title":"A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus","volume":"73","author":"Le Prise","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF02067069","article-title":"Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer","volume":"16","author":"Nygaard","year":"1992","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib33","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1741-7015-2-35","article-title":"Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis","volume":"2","author":"Malthaner","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib40","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2009.11.007_bib41","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.ijrobp.2008.06.929","article-title":"Individual patient data-based meta-analysis assessing the effect of preoperative chemoradiotherapy in resectable oesophageal carcinoma","volume":"72","author":"Thirion","year":"2008","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semradonc.2006.09.008","article-title":"Definitive chemoradiation in the management of locally advanced esophageal cancer","volume":"17","author":"Suntharalingam","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib43","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11136-008-9365-y","article-title":"Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials","volume":"17","author":"Bonnetain","year":"2008","journal-title":"Qual Life Res"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib45","first-page":"365","article-title":"Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?","volume":"12","author":"Crehange","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib46","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","article-title":"Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus","volume":"23","author":"Stahl","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18S","key":"10.1016\/j.critrevonc.2009.11.007_bib47","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1200\/jco.2007.25.18_suppl.4511","article-title":"Preoperative chemotherapy (CTX) versus preoperative chemoradiotherapy (CRTX) in locally advanced esophagogastric adenocarcinomas: first results of a randomized phase III trial","volume":"25","author":"Stahl","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2009.03.018","article-title":"EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach","volume":"92","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2009.11.007_bib49","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1200\/JCO.2007.12.3471","article-title":"Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: federation Francophone de Cancerologie Digestive 9102","volume":"25","author":"Crehange","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809002315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T10:41:21Z","timestamp":1590489681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842809002315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1040842809002315"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2009.11.007","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}